The role of LMNB2 as a diagnostic and prognostic biomarker in lung adenocarcinoma

被引：2
|
作者：
Xu, Shengshan [1 ]
Lu, Zhuming [1 ]
机构：
[1] Jiangmen Cent Hosp, Dept Thorac Surg, Jiangmen, Guangdong, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2025年 / 48卷 / 02期
关键词：
LMNB2; LUAD; Biomarker; Prognosis; Tumor immune microenvironment; CANCER;
D O I：
10.1016/j.asjsur.2024.08.056
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1175 / 1177
页数：3
相关论文
共 50 条
  • [41] PRSS3 is a potential prognostic biomarker for lung adenocarcinoma
    Nie, Lu
    Zhang, Xueqing
    Wu, Jie
    TRANSLATIONAL CANCER RESEARCH, 2025, 14 (02)
  • [42] NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma
    Li, Chao
    Meng, Jun
    Zhang, Tongtong
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [43] PSF3 IS A NOVEL PROGNOSTIC BIOMARKER IN LUNG ADENOCARCINOMA
    Hokka, D.
    Maniwa, Y.
    Tane, S.
    Tauchi, S.
    Nishio, W.
    Yoshimura, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
  • [44] KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer
    Yanan Zhang
    Zeyang Chen
    Aifang Jiang
    Guanqi Gao
    Scientific Reports, 12
  • [45] NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma
    Chao Li
    Jun Meng
    Tongtong Zhang
    Scientific Reports, 12
  • [46] MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma
    Kim, Yeseul
    Sim, Jongmin
    Kim, Hyunsung
    Bang, Seong Sik
    Jee, Seungyun
    Park, Sungeon
    Jang, Kiseok
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2019, 53 (06) : 354 - 360
  • [47] LNX1-AS2 as a Key Prognostic and Immunotherapy Response Biomarker for Lung Adenocarcinoma
    Wang, Xiuxiu
    Yan, Guanzhong
    Zhang, Xiaoying
    Li, Dongbing
    Li, Guangyi
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [48] E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma
    Lin, Shengcheng
    Yu, Xiangyang
    Yan, Haojie
    Xu, Yafei
    Ma, Kai
    Wang, Xiaoliang
    Liu, Yeqing
    Xie, Ahuan
    Yu, Zhentao
    MEDICINE, 2024, 103 (03) : E34342
  • [49] DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma
    Liu, Xu-Sheng
    Zeng, Jing
    Zhang, Yao-Hua
    Zhang, Yu
    Gao, Yan
    Liu, Chao
    Pei, Zhi-Jun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (03): : 818 - 834
  • [50] Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma
    Zheng, Qingzhu
    Li, Mingjie
    Qiu, Yingkun
    Yang, Jiahao
    Cao, Yingping
    HELIYON, 2024, 10 (01)
12345